Background illustration for clinical trials search

Paid Clinical Trials Bloomfield Hills

Discover 1,711 paid clinical trials in Bloomfield Hills, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
Location: Troy MI, Avon OH, Cleveland OH, Mentor OH, Orange OH,
Sponsor: Pfizer

Sex: Male

Age: 18+

Code: NCT07028853

Phase 3, Recruiting

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: Troy MI, Gahanna OH, Merrillville IN, Glenview IL,
Sponsor: Dendreon

Sex: Male

Age: 18+

Code: NCT06134232

Phase 2, Recruiting

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

for
Non-muscle-invasive Bladder Cancer
Location: Troy MI, Columbus OH, Annapolis MD, Boston MA,
Sponsor: SURGE Therapeutics

Sex: All

Age: 18+

Code: NCT05710848

Phase 1, Phase 2, Recruiting

A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout

for
Uncontrolled Gout
Location: Troy MI, Saint Clair Shores MI, Lansing MI,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT07388498

Phase 3, Recruiting

A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants

for
Gout
Location: Troy MI, Sterling Heights MI, Saint Clair Shores MI,
Sponsor: Crystalys Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07535034

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Intra-Articular Allocetra in Patients With Primary Knee Osteoarthritis

for
Primary Knee Osteoarthritis
Location: Troy MI, New Orleans LA, Longwood FL, Miami FL
Sponsor: Enlivex Therapeutics Ltd.

Sex: All

Age: 64+

Code: NCT07580716

Phase 2, Recruiting

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

for
Type 2 Diabetes, Cortisol Excess
Location: Troy MI, Columbus OH, Chicago IL, Cincinnati OH,
Sponsor: Sparrow Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07296484

Phase 2, Recruiting

An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.

for
Hypertension (HTN)
Location: Troy MI, Chicago IL, Ft. Washington MD, Berlin NJ,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07543120

Phase 2, Recruiting

Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD

for
Rhinovirus Infection
Location: Troy MI, Dearborn MI, Columbus OH, Valparaiso IN,
Sponsor: Altesa Biosciences, Inc.

Sex: All

Age: 40 - 70+

Code: NCT07610395

Phase 2, Recruiting

A Study of Dotinurad Versus Allopurinol in Participants With Gout

for
Gout
Location: Troy MI, Sterling Heights MI, Saint Clair Shores MI,
Sponsor: Crystalys Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07089875

Phase 3, Recruiting

A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

for
Tophaceous Gout
Location: Troy MI, Sterling Heights MI, Saint Clair Shores MI,
Sponsor: Crystalys Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07089888

Phase 3, Recruiting

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

for
Pulmonary Disease, Chronic Obstructive
Location: Troy MI, Garden City MI, Allen Park MI, Chicago IL,
Sponsor: GlaxoSmithKline

Sex: All

Age: 40 - 70+

Code: NCT06961214

Phase 3, Recruiting

The Vanguard Study: Testing a New Way to Screen for Cancer

for
Bladder Carcinoma, Breast Carcinoma, Colorectal Carcinoma,
Location: Troy MI, Royal Oak MI, West Bloomfield MI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 45 - 70+

Code: NCT06995898

Recruiting

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

for
Cutaneous Squamous Cell Carcinoma (CSCC)
Location: Troy MI, Midland MI, Cleveland OH, Springfield OH,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06585410

Phase 3, Recruiting

Active Surveillance SNEP Assay Registry Trial for Prostate Cancer

for
Prostate Cancer Aggressiveness
Location: Royal Oak MI
Sponsor: Immunis.AI

Sex: Male

Age: 40 - 70+

Code: NCT04052048

Recruiting

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

for
Non-Muscle Invasive Bladder Cancer
Location: Royal Oak MI, Detroit MI, Chicago IL, Syracuse NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06319820

Phase 3, Recruiting

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

for
Non-Muscle Invasive Bladder Neoplasms
Location: Royal Oak MI, Gahanna OH, Centerville OH, Pittsburgh PA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06919965

Phase 3, Recruiting

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

for
Urothelial Cancer, Urinary Bladder Neoplasms
Location: Royal Oak MI, Fort Wayne IN, Fairfield OH, Niles IL,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07566156

Phase 3, Recruiting

A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease

for
Proteinuric Kidney Disease
Location: Pontiac MI, Dearborn MI, Flint MI, Cleveland OH,
Sponsor: Maze Therapeutics

Sex: All

Age: 18 - 68

Code: NCT06830629

Phase 2, Recruiting

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

for
Non-small Cell Lung Cancer
Location: Royal Oak MI, Cincinnati OH, Edgewood KY, Rochester NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06561386

Phase 3, Recruiting